D-Tails Research

D-TAILS S.R.L. SB Disruptive Technological Advances in Life Sciences Società Benefit D-TAILS is a deep-tech life science company focused on the development of disruptive technologies for early, non-invasive disease detection. Our research spans neurodegenerative diseases and oncology, with a strong emphasis on biological sensing, advanced imaging, and AI-driven data analysis. Key activities include: Development of novel biocompatible markers for the early detection of Alzheimer’s disease, targeting Tau aggregates in the retina. Development of non-invasive urine-based screening tests for breast, prostate, and pancreatic cancers, leveraging biological olfaction and VOC analysis. Study of Caenorhabditis elegans as a living biosensor, investigating behavioral and neural responses to cancer-related volatile organic compounds (VOCs). D-TAILS also develops advanced imaging platforms, including wide-field microscopy, structured illumination, adaptive optics, and integrated microfluidic solutions, designed to enable scalable, high-content biological assays.